Skip to main content

Perforomist News

ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma

TUESDAY, Oct. 29, 2024 – For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each a...

FDA Medwatch Alert: Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements

[UPDATED 04-15-2011] To further evaluate the safety of Long-Acting Beta-Agonists (LABAs) when used in combination with inhaled corticosteroids for the treatment of asthma, the FDA is requiring the...

FDA Approves Merck's Dulera (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jun 24, 2010 - Merck today announced that the U.S. Food and Drug Administration (FDA) has approved Dulera (mometasone furoate and formoterol fumarate...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Perforomist patient information at Drugs.com